273 related articles for article (PubMed ID: 30599085)
1. Improvements in treatment planning calculations motivated by tightening IMRT QA tolerances.
Stambaugh C; Gagneur J; Uejo A; Clouser E; Ezzell G
J Appl Clin Med Phys; 2019 Jan; 20(1):250-257. PubMed ID: 30599085
[TBL] [Abstract][Full Text] [Related]
2. A clinically relevant IMRT QA workflow: Design and validation.
Stambaugh C; Ezzell G
Med Phys; 2018 Apr; 45(4):1391-1399. PubMed ID: 29481698
[TBL] [Abstract][Full Text] [Related]
3. Institutional patient-specific IMRT QA does not predict unacceptable plan delivery.
Kry SF; Molineu A; Kerns JR; Faught AM; Huang JY; Pulliam KB; Tonigan J; Alvarez P; Stingo F; Followill DS
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1195-201. PubMed ID: 25442044
[TBL] [Abstract][Full Text] [Related]
4. A method to reconstruct and apply 3D primary fluence for treatment delivery verification.
Liu S; Mazur TR; Li H; Curcuru A; Green OL; Sun B; Mutic S; Yang D
J Appl Clin Med Phys; 2017 Jan; 18(1):128-138. PubMed ID: 28291913
[TBL] [Abstract][Full Text] [Related]
5. Clinical implementation of Dosimetry Check™ for TomoTherapy
Chung E; Kwon D; Park T; Kang H; Chung Y
J Appl Clin Med Phys; 2018 Nov; 19(6):193-199. PubMed ID: 30354001
[TBL] [Abstract][Full Text] [Related]
6. National survey of patient specific IMRT quality assurance in China.
Pan Y; Yang R; Zhang S; Li J; Dai J; Wang J; Cai J
Radiat Oncol; 2019 Apr; 14(1):69. PubMed ID: 31023348
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of one algorithm used to modify a planned DVH with data from actual dose delivery.
Ma T; Podgorsak MB; Kumaraswamy LK
J Appl Clin Med Phys; 2016 Sep; 17(5):273-282. PubMed ID: 27685140
[TBL] [Abstract][Full Text] [Related]
8. DVH analysis using a transmission detector and model-based dose verification system as a comprehensive pretreatment QA tool for VMAT plans: Clinical experience and results.
Mohamed Yoosuf AB; AlShehri S; Alhadab A; Alqathami M
J Appl Clin Med Phys; 2019 Nov; 20(11):80-87. PubMed ID: 31605456
[TBL] [Abstract][Full Text] [Related]
9. Using a novel dose QA tool to quantify the impact of systematic errors otherwise undetected by conventional QA methods: clinical head and neck case studies.
Chan MF; Li J; Schupak K; Burman C
Technol Cancer Res Treat; 2014 Feb; 13(1):57-67. PubMed ID: 23819494
[TBL] [Abstract][Full Text] [Related]
10. Biological consequences of MLC calibration errors in IMRT delivery and QA.
Moiseenko V; Lapointe V; James K; Yin L; Liu M; Pawlicki T
Med Phys; 2012 Apr; 39(4):1917-24. PubMed ID: 22482613
[TBL] [Abstract][Full Text] [Related]
11. Clinically relevant quality assurance for intensity modulated radiotherapy plans: gamma maps and DVH-based evaluation.
Caivano R; Califano G; Fiorentino A; Cozzolino M; Oliviero C; Pedicini P; Clemente S; Chiumento C; Fusco V
Cancer Invest; 2014 Mar; 32(3):85-91. PubMed ID: 24499109
[TBL] [Abstract][Full Text] [Related]
12. To propose adding index of achievement (IOA) to IMRT QA process.
Kim DS; Kim S; Kang SH; Kim TH; Park SH; Kim KH; Cho MS; Shin DS; Noh YY; Chung JB; Suh TS
Radiat Oncol; 2018 Jun; 13(1):112. PubMed ID: 29903025
[TBL] [Abstract][Full Text] [Related]
13. Dependence of achievable plan quality on treatment technique and planning goal refinement: a head-and-neck intensity modulated radiation therapy application.
Qi XS; Ruan D; Lee SP; Pham A; Kupelian P; Low DA; Steinberg M; Demarco J
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):817-24. PubMed ID: 25752396
[TBL] [Abstract][Full Text] [Related]
14. Three IMRT advanced planning tools: A multi-institutional side-by-side comparison.
Lu L; Sheng Y; Donaghue J; Liu Shen Z; Kolar M; Wu QJ; Xia P
J Appl Clin Med Phys; 2019 Aug; 20(8):65-77. PubMed ID: 31364798
[TBL] [Abstract][Full Text] [Related]
15. An analysis of tolerance levels in IMRT quality assurance procedures.
Basran PS; Woo MK
Med Phys; 2008 Jun; 35(6):2300-7. PubMed ID: 18649462
[TBL] [Abstract][Full Text] [Related]
16. Clinical introduction of a linac head-mounted 2D detector array based quality assurance system in head and neck IMRT.
Korevaar EW; Wauben DJ; van der Hulst PC; Langendijk JA; Van't Veld AA
Radiother Oncol; 2011 Sep; 100(3):446-52. PubMed ID: 21963288
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of DVH-based treatment plan verification in addition to gamma passing rates for head and neck IMRT.
Visser R; Wauben DJ; de Groot M; Steenbakkers RJ; Bijl HP; Godart J; van't Veld AA; Langendijk JA; Korevaar EW
Radiother Oncol; 2014 Sep; 112(3):389-95. PubMed ID: 25154319
[TBL] [Abstract][Full Text] [Related]
18. A quality assurance method that utilizes 3D dosimetry and facilitates clinical interpretation.
Oldham M; Thomas A; O'Daniel J; Juang T; Ibbott G; Adamovics J; Kirkpatrick JP
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):540-6. PubMed ID: 22361085
[TBL] [Abstract][Full Text] [Related]
19. Experience-based quality control of clinical intensity-modulated radiotherapy planning.
Moore KL; Brame RS; Low DA; Mutic S
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):545-51. PubMed ID: 21277097
[TBL] [Abstract][Full Text] [Related]
20. Correlation of phantom-based and log file patient-specific QA with complexity scores for VMAT.
Agnew CE; Irvine DM; McGarry CK
J Appl Clin Med Phys; 2014 Nov; 15(6):4994. PubMed ID: 25493524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
